|
Originally published In Press as doi:10.1074/jbc.M503511200 on June 23, 2005
J. Biol. Chem., Vol. 280, Issue 33, 29820-29827, August 19, 2005
Repulsive Guidance Molecule (RGMa), a DRAGON Homologue, Is a Bone Morphogenetic Protein Co-receptor*
Jodie L. Babitt ¶,
Ying Zhang ,
Tarek A. Samad||,
Yin Xia **,
Jie Tang ,
Jason A. Campagna||,
Alan L. Schneyer**,
Clifford J. Woolf||, and
Herbert Y. Lin 
From the
Program in Membrane Biology and Division of Nephrology, Department of Medicine, the ||Neural Plasticity Research Group, Department of Anesthesia and Critical Care, and the **Reproductive Endocrine Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02129
Bone morphogenetic proteins (BMPs) are members of the transforming growth factor (TGF- ) superfamily of ligands, which regulate many mammalian physiologic and pathophysiologic processes. BMPs exert their effects through type I and type II serine/threonine kinase receptors and the Smad intracellular signaling pathway. Recently, the glycosylphosphatidylinositol (GPI)-anchored protein DRAGON was identified as a co-receptor for BMP signaling. Here, we investigate whether a homologue of DRAGON, repulsive guidance molecule (RGMa), is similarly involved in the BMP signaling pathway. We show that RGMa enhances BMP, but not TGF- , signals in a ligand-dependent manner in cell culture. The soluble extracellular domain of RGMa fused to human Fc (RGMa.Fc) forms a complex with BMP type I receptors and binds directly and selectively to radiolabeled BMP-2 and BMP-4. RGMa mediates BMP signaling through the classical BMP signaling pathway involving Smad1, 5, and 8, and it up-regulates endogenous inhibitor of differentiation (Id1) protein, an important downstream target of BMP signals. Finally, we demonstrate that BMP signaling occurs in neurons that express RGMa in vivo. These data are consistent with a role for RGMa as a BMP co-receptor.
Received for publication, March 31, 2005
, and in revised form, June 10, 2005.
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Both authors contributed equally to this work.
¶ Supported in part by National Institutes of Health Grant F32 DK-068997.
 Supported in part by National Institutes of Health Grants DK-57521 and DK-071837. To whom correspondence should be addressed: Program in Membrane Biology, 149 13th St., MGH-East CNY-8216, Charlestown, MA 02129. Tel.: 617-726-5661; Fax: 617-726-5669; E-mail: hlin{at}partners.org.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Asai-Coakwell, C. R. French, M. Ye, K. Garcha, K. Bigot, A. G. Perera, K. Staehling-Hampton, S. C. Mema, B. Chanda, A. Mushegian, et al.
Incomplete penetrance and phenotypic variability characterize Gdf6-attributable oculo-skeletal phenotypes
Hum. Mol. Genet.,
March 15, 2009;
18(6):
1110 - 1121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Xia, J. L. Babitt, Y. Sidis, R. T. Chung, and H. Y. Lin
Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin
Blood,
May 15, 2008;
111(10):
5195 - 5204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kuns-Hashimoto, D. Kuninger, M. Nili, and P. Rotwein
Selective binding of RGMc/hemojuvelin, a key protein in systemic iron metabolism, to BMP-2 and neogenin
Am J Physiol Cell Physiol,
April 1, 2008;
294(4):
C994 - C1003.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. C. Kirkbride, T. A. Townsend, M. W. Bruinsma, J. V. Barnett, and G. C. Blobe
Bone Morphogenetic Proteins Signal through the Transforming Growth Factor-{beta} Type III Receptor
J. Biol. Chem.,
March 21, 2008;
283(12):
7628 - 7637.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. D. Upton, L. Long, R. C. Trembath, and N. W. Morrell
Functional Characterization of Bone Morphogenetic Protein Binding Sites and Smad1/5 Activation in Human Vascular Cells
Mol. Pharmacol.,
February 1, 2008;
73(2):
539 - 552.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Wordinger and A. F. Clark
Bone Morphogenetic Proteins and Their Receptors in the Eye
Experimental Biology and Medicine,
September 1, 2007;
232(8):
979 - 992.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Xia, P. B. Yu, Y. Sidis, H. Beppu, K. D. Bloch, A. L. Schneyer, and H. Y. Lin
Repulsive Guidance Molecule RGMa Alters Utilization of Bone Morphogenetic Protein (BMP) Type II Receptors by BMP2 and BMP4
J. Biol. Chem.,
June 22, 2007;
282(25):
18129 - 18140.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Conrad, H. Genth, F. Hofmann, I. Just, and T. Skutella
Neogenin-RGMa Signaling at the Growth Cone Is Bone Morphogenetic Protein-independent and Involves RhoA, ROCK, and PKC
J. Biol. Chem.,
June 1, 2007;
282(22):
16423 - 16433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-S. Zhang, S. A. Anderson, K. R. Meyers, C. Hernandez, R. S. Eisenstein, and C. A. Enns
Evidence That Inhibition of Hemojuvelin Shedding in Response to Iron Is Mediated through Neogenin
J. Biol. Chem.,
April 27, 2007;
282(17):
12547 - 12556.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. K Mueller, T. Yamashita, G. Schaffar, and R. Mueller
The role of repulsive guidance molecules in the embryonic and adult vertebrate central nervous system
Phil Trans R Soc B,
September 29, 2006;
361(1473):
1513 - 1529.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S J. Lin, T. F Lerch, R. W Cook, T. S Jardetzky, and T. K Woodruff
The structural basis of TGF-{beta}, bone morphogenetic protein, and activin ligand binding.
Reproduction,
August 1, 2006;
132(2):
179 - 190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Umulis, M. Serpe, M. B. O'Connor, and H. G. Othmer
Robust, bistable patterning of the dorsal surface of the Drosophila embryo
PNAS,
August 1, 2006;
103(31):
11613 - 11618.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Truksa, H. Peng, P. Lee, and E. Beutler
Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6
PNAS,
July 5, 2006;
103(27):
10289 - 10293.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mazerbourg and A. J.W. Hsueh
Genomic analyses facilitate identification of receptors and signalling pathways for growth differentiation factor 9 and related orphan bone morphogenetic protein/growth differentiation factor ligands
Hum. Reprod. Update,
July 1, 2006;
12(4):
373 - 383.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Matsunaga, H. Nakamura, and A. Chedotal
Repulsive guidance molecule plays multiple roles in neuronal differentiation and axon guidance.
J. Neurosci.,
May 31, 2006;
26(22):
6082 - 6088.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Hata, M. Fujitani, Y. Yasuda, H. Doya, T. Saito, S. Yamagishi, B. K. Mueller, and T. Yamashita
RGMa inhibition promotes axonal growth and recovery after spinal cord injury
J. Cell Biol.,
April 10, 2006;
173(1):
47 - 58.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Whitman and L. Raftery
TGF{beta} signaling at the summit
Development,
October 1, 2005;
132(19):
4205 - 4210.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|